| Original language | English |
|---|---|
| Pages (from-to) | 881-886 |
| Number of pages | 6 |
| Journal | Blood Advances |
| Volume | 10 |
| Issue number | 3 |
| DOIs | |
| State | Published - 10 Feb 2026 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
Decitabine-cedazuridine in patients with MDS and TP53 mutations
- Samuel Urrutia
- , Koji Sasaki
- , Alex Bataller
- , Hagop Kantarjian
- , Guillermo Montalban-Bravo
- , James McCloskey
- , Elizabeth A. Griffiths
- , Karen Yee
- , Amer Zeidan
- , Michael Savona
- , Aram Oganesian
- , Yuri Sano
- , Harold N. Keer
- , Guillermo Garcia-Manero
- Washington University St. Louis
- University of Texas MD Anderson Cancer Center
- Roswell Park Cancer Institute
- Princess Margaret Hospital
- Yale University
- Vanderbilt University
- Taiho Pharmaceutical Co., Ltd.
Research output: Contribution to journal › Article › peer-review
4
Scopus
citations